Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adnexal Tumor”

4,526 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,526 results

Not applicableEnrolling By InvitationNCT07035067
What this trial is testing

Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada

Who this might be right for
Ovarian CancerCaregiver BurdenPatient Burden
PeriPharm 150
Not applicableUnknownNCT04065100
What this trial is testing

Sebum Measurement in Newborn to Detect Hyperexposure to Androgens

Who this might be right for
Polycystic Ovary Syndrome
Homerton University Hospital NHS Foundation Trust 200
Early research (Phase 1)Study completedNCT02897375
What this trial is testing

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Who this might be right for
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more
Emory University 71
Not applicableEnded earlyNCT01775176
What this trial is testing

Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & Adipose

Who this might be right for
Polycystic Ovary Syndrome
Pennington Biomedical Research Center 17
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Ended earlyNCT02432690
What this trial is testing

BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation

Who this might be right for
CancerOvarian Cancer
Sumitomo Pharma America, Inc. 13
Not applicableWithdrawnNCT05512260
What this trial is testing

Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs

Who this might be right for
Neoplasm, ColorectalNeoplasm, BreastNeoplasm, Ovarian
Karolinska Institutet
Very early researchNot Yet RecruitingNCT06825455
What this trial is testing

Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancersPeritoneal (metastatic) Cancer
Peking University 18
Early research (Phase 1)Active Not RecruitingNCT02627443
What this trial is testing

Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Metastatic Fallopian Tube CarcinomaMetastatic Ovarian CarcinomaMetastatic Primary Peritoneal Carcinoma+9 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT06412510
What this trial is testing

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerPancreatic Adenocarcinoma
Case Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00453310
What this trial is testing

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTeratoma+1 more
Memorial Sloan Kettering Cancer Center 10
Not applicableEnded earlyNCT00287482
What this trial is testing

Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.

Who this might be right for
Ovarian CancerBreast Cancer
Women and Infants Hospital of Rhode Island 20
Testing effectiveness (Phase 2)UnknownNCT04590625
What this trial is testing

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zhongshan Hospital Xiamen University 58
Not applicableUnknownNCT03784976
What this trial is testing

Iyengar Yoga Therapy for Dysmenorrhea and Endometriosis

Who this might be right for
Secondary DysmenorrheaDysmenorrheaDysmenorrhea Secondary+6 more
University of Illinois at Urbana-Champaign 90
Not applicableStudy completedNCT05062135
What this trial is testing

Progesterone Action on Endometrium of PCOS

Who this might be right for
Polycystic OvaryProgesterone Resistance
University of Sao Paulo General Hospital 36
Testing effectiveness (Phase 2)Ended earlyNCT01383408
What this trial is testing

Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection

Who this might be right for
Lung CancerBreast CancerOvarian Cancer
Schillerhoehe Hospital 752
Early research (Phase 1)Ended earlyNCT00637390
What this trial is testing

A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
University of Michigan Rogel Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03562897
What this trial is testing

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Who this might be right for
CarcinomaOvarian NeoplasmEndocrine Gland Neoplasm+10 more
Catalysis SL 40
Early research (Phase 1)Ended earlyNCT06457997
What this trial is testing

PHN-010 in Patients With Advanced Solid Tumors

Who this might be right for
Lung CancerColon CancerEndometrial Cancer+4 more
Pheon Therapeutics 26
Early research (Phase 1)Looking for participantsNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Load More Results